重置

全部指南(12470)

2002 NHLBI 成人高胆固醇的检测、评估与治疗(成人治疗专家组III)

美国国家心脏、肺和血液研究所(NHLBI,National Heart, Lung, and Blood Institute) 血液科 2002-01-01
New features of ATP III include: Aggressive treatment of persons who are at relatively high risk for coronary heart disease due to multiple risk factors Use of the lipoprotein profile as the first test for high cholesterol A new level at which low HDL (high density lipoprotein) becomes a major heart disease risk factor A new set of "Therapeutic Lifestyle Changes" to improve cholesterol levels An increased focus on a cluster of heart disease risk factors knows as "the metabolic syndrome" Increased attention to the treatment of high triglycerides

卡培他滨治疗进展期胃癌

英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence) 肿瘤科,消化科 2010-07-24
Guideline Objective(s) To evaluate the clinical effectiveness and cost-effectiveness of capecitabine for the treatment of advanced gastric cancer.

2007USPSTF 高血压筛查:美国预防医学工作组推荐声明

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) 心血管内科 2007-01-01
  Guideline Objective(s) To summarize the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for high blood pressure and the supporting evidence. To update the 2003 USPSTF recommendations for screening for high blood pressure.

2009 UMHS临床实践指南:原发性高血压

密西根大学卫生系统(UMHS,University of Michigan Health System) 心血管内科 2009-01-01
  Guideline Objective(s) To accurately diagnose hypertension To improve blood pressure (BP) control To decrease hypertension-related morbidity and mortality To encourage patient's self-involvement To provide appropriate education and follow-up To provide cost-effective care  

2006AACE 高血压的诊断和治疗临床实践指南

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) 心血管内科,内分泌科 2006-03-01
  The American Association of Clinical Endocrinologists (AACE) proposes these guidelines to clarify what is known about the treatment of hypertension based on the best current evidence. Unlike other clinical practice guidelines, however, those presented in this report will focus on identifying and managing hypertension secondary to or coincident with endocrinopathies. The AACE contends that understanding the associated pathophysiologic features of hypertension will guide appropriate treatment and help physicians anticipate the usefulness of evolving therapies, such as blockade of the renin-angiotensin system for retarding the progression of retinopathy and nephropathy in patients with diabetes 

2004 NIH/NHLBI 美国国家联合委员会关于高血压预防、检测、评价和治疗第7次报告(JNC-7)

美国国家卫生研究院(NIH,The National Institutes of Health) 心血管内科 2004-01-01
JNC7的背景是什么? 30多年以前美国心肺血研究所(the national Heart,lung,and blood institute,NHLBI)组建了全国高血压教育计划协调委员会,由来自39个专业学会或公共事业组织和7个联邦机构的人员参与,其主要功能之一是起草指南与建议,以提高对高血压的认知、预防治疗和控制水平. JNC-7与1997年发表的JNC-6相比,从风格到内容都有重大变化。变化的依据是近6年中大量关于高血压防治的前瞻性随机临床试验,包括ALLHAT、LIFE等所获取的最新证据。JNC-7遵循循证医学的原则,对高血压防治提出了新思路,制定了新策略,对我国高血压防治指南有重要参考价值。

2006 NICE 成人高血压的初级护理

英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence) 心血管内科 2006-06-01
此指南已于2011年8月更新 The guidelines provide evidence-based recommendations for establishing a diagnosis of hypertension. Estimation and monitoring of blood pressure is discussed in detail. Indications for consultant referral are also briefly covered.

2009 ESC/ERS肺动脉高压诊断和治疗指南

欧洲心脏病学会(ESC,European Society of Cardiology) 心血管内科,呼吸科 2009-08-01
欧洲心脏病协会(ESC)和欧洲呼吸病协会(ERS)撰写并得到国际心肺移植协会认可的《肺动脉高压诊断和治疗指南》于2009年8月发布。 请读者将此“指南”与2009年3月发布的由美国心脏病学院基金会(ACCF)和美国心脏学会(AHA)共同编写的"ACCF/AHA肺动脉高压专家共识"相区别。 二者的区别请参见该指南解读。

2007ESC 动脉高血压治疗指南

欧洲心脏病学会(ESC,European Society of Cardiology) 心血管内科 2007-01-01
For several years the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided not to produce their own guidelines on the diagnosis and treatment of hypertension but to endorse the guidelines on hypertension issued by the World Health Organization (WHO) and International Society of Hypertension (ISH)1,2 with some adaptation to reflect the situation in Europe. However, in 2003 the decision was taken to publish ESH/ESC specific guidelines3 based on the fact that, because the WHO/ISH Guidelines address countries widely varying in the extent of their health care and availability of economic resource, they contain diagnostic and therapeutic recommendations that may be not totally appropriate for European countries. In Europe care provisions may often allow a more in-depth diagnostic assessment of cardiovascular risk and organ damage of hypertensive individuals as well as a wider choice of antihypertensive treatment.

2001AAP 美国Down综合症儿童的健康监督

美国儿科学会(AAP,American Academy of Pediatrics) 精神科 2001-02-02
  These guidelines are designed to assist the pediatrician in caring for the child in whom the diagnosis of Down syndrome has been confirmed by karyotype. Although the pediatrician’s initial contact with the child is usually during infancy, occasionally the pregnant woman who has been given the prenatal diagnosis of Down syndrome will be referred for counseling.Therefore, these guidelines offer advice for this situation as well.